NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 52 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,587 | -100.0% | 1,000 | -100.0% | 0.00% | -100.0% |
| Q4 2020 | $64,681,000 | -0.6% | 46,390,000 | 0.0% | 0.06% | -15.8% |
| Q3 2020 | $65,053,000 | -38.2% | 46,390,000 | -23.2% | 0.08% | -37.7% |
| Q2 2020 | $105,347,000 | +23.9% | 60,425,000 | -5.5% | 0.12% | +7.0% |
| Q1 2020 | $85,025,000 | -24.2% | 63,975,000 | -11.4% | 0.11% | +10.7% |
| Q4 2019 | $112,242,000 | +22.7% | 72,175,000 | +8.4% | 0.10% | +14.4% |
| Q3 2019 | $91,443,000 | +28.3% | 66,555,000 | +23.5% | 0.09% | +36.4% |
| Q2 2019 | $71,274,000 | -12.7% | 53,905,000 | -12.3% | 0.07% | -18.5% |
| Q1 2019 | $81,630,000 | +5.0% | 61,500,000 | -5.6% | 0.08% | -4.7% |
| Q4 2018 | $77,766,000 | -39.9% | 65,145,000 | -13.5% | 0.08% | -27.4% |
| Q3 2018 | $129,343,000 | +6.0% | 75,285,000 | -10.2% | 0.12% | -1.7% |
| Q2 2018 | $122,059,000 | – | 83,875,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CSS LLC/IL | 15,659,000 | $23,207,687 | 1.52% |
| SONA ASSET MANAGEMENT (US) LLC | 17,500,000 | $26,317,952 | 1.09% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 26,765,000 | $40,113,099 | 0.86% |
| Warberg Asset Management LLC | 1,271,000 | $1,885,846 | 0.38% |
| SSI INVESTMENT MANAGEMENT LLC | 2,296,000 | $3,406,116 | 0.28% |
| Paloma Partners Management Co | 3,125,000 | $4,694,590 | 0.16% |
| FRANKLIN RESOURCES INC | 54,750,000 | $81,769,125 | 0.04% |
| Rock Springs Capital Management LP | 1,000,000 | $1,497,950 | 0.04% |
| LORD, ABBETT & CO. LLC | 4,666,000 | $6,922 | 0.03% |
| D. E. Shaw & Co., Inc. | 14,351,000 | $21,373,197 | 0.02% |